Sotatercept Improves Hemodynamics and Right Heart Function in High-Risk Pulmonary Arterial Hypertension (PAH): Results from ZENITH Trial
30 August 2025 (12:30 - 13:15)
Organised by: 
About the speakers
University of Michigan, Ann Arbor (United States of America)
Merck Research Labs, Lisboa (Portugal)
6 More presentations in this session
Access the full session
The Event
ESC Congress 2025
30 August 2025
12:30 CET
